Bristol Myers Squibb Exercises Option to Extend Targeted Protein Degradation Partnership with Evotec

Author's Avatar
Apr 26, 2021
  • BRISTOL MYERS SQUIBB EXTENDS COLLABORATION WITH EVOTEC IN THE FIELD OF TARGETED PROTEIN DEGRADATION
  • EXTENSION TRIGGERS AN ADDITIONAL COLLABORATION PAYMENT TO EVOTEC'S FAST-GROWING PANOMICS PLATFORM
  • PARTNERSHIP AIMS TO FURTHER EXPAND THE PROTEIN DEGRADATION PIPELINE